Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Subklinische manifestatie MS bij asymptomatische familieleden
jun 2017 | Multipele Sclerose